Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer.
about
Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancerInhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy optionsLithium chloride promotes host resistance against Pseudomonas aeruginosa keratitis.In vitro antiviral effect of germacrone on feline calicivirus.Antiviral effect of lithium chloride on feline calicivirus in vitro.Towards a Unified Understanding of Lithium Action in Basic Biology and its Significance for Applied Biology.
P2860
Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lithium chloride and inhibitio ...... apy for serous ovarian cancer.
@en
Lithium chloride and inhibitio ...... apy for serous ovarian cancer.
@nl
type
label
Lithium chloride and inhibitio ...... apy for serous ovarian cancer.
@en
Lithium chloride and inhibitio ...... apy for serous ovarian cancer.
@nl
prefLabel
Lithium chloride and inhibitio ...... apy for serous ovarian cancer.
@en
Lithium chloride and inhibitio ...... apy for serous ovarian cancer.
@nl
P2093
P2860
P1476
Lithium chloride and inhibitio ...... apy for serous ovarian cancer.
@en
P2093
Akiva P Novetsky
David G Mutch
Dominic M Thompson
Israel Zighelboim
Matthew A Powell
Paul J Goodfellow
Premal H Thaker
P2860
P304
P356
10.1097/IGC.0B013E31827CFECB
P577
2013-02-01T00:00:00Z